Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
orphan drug
Pharma
Orphan drug sales to surge past $400B in 2032: report
Despite a few recent policy wins, the orphan drug market remains vulnerable to a more scrutinizing FDA and potential pricing pressures.
Angus Liu
Mar 12, 2026 8:20am
Senate revives Orphan Cures Act in Trump's tax bill
Jun 30, 2025 10:09am
Orphan Cures Act dropped from Senate reconciliation bill
Jun 17, 2025 11:30am
Vyvgart, Cabenuva, Lumakras top Trinity launch success analysis
Mar 12, 2025 2:13pm
Orphan drug market to reach $270B by 2028: Evaluate
Apr 24, 2024 12:01am
AZ challenges the IRA's 'unintended consequences' with lawsuit
Aug 25, 2023 11:26am
